Review of molecular biological studies on acute lymphoblastic leukemia treated by modified shengmaiyin

The objective was to explore the pharmacological mechanism of modified shengmaiyin (MSMY) in the treatment of acute lymphoblastic leukemia (ALL) by network pharmacology analysis. The effective components and predicted targets of MSMY were collected from TCMSP and Swiss target prediction databases, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Dongyu, Gu, Mengyu, Du, Fuquan, Zhao, Yuting, Gao, Mingjie, Hao, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256333/
https://www.ncbi.nlm.nih.gov/pubmed/37335634
http://dx.doi.org/10.1097/MD.0000000000034013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256333/
https://www.ncbi.nlm.nih.gov/pubmed/37335634
http://dx.doi.org/10.1097/MD.0000000000034013

Ejemplares similares